In a study comparing IGFBP-1, 3 and 4 levels in human normal liver, cirrhotic liver and HCC, the expression of all three IGFBP-3 mRNA levels was significantly reduced in HCC [31]. This evidence concerns the gene IGFBP3 and hepatocellular carcinoma.